AJ

Aditya Jaiswal

Director Director DIN 08421553
DIN 08421553 First appointment Apr 2019 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Aditya Jaiswal

Data last updated:

Aditya Jaiswal was a Director at Medione Pharmaceuticals Private Limited (2019–2023) and Additional Director at Dewrock Infraprojects Private Limited (2019). The companies operate in Chemicals and Real Estate and Construction.

DIN 08421553
Primary Designation Director
Industry Chemicals
First Appointment 29 Apr 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 May 20192019₹1.9 Lakh (FY 2020)Active
Additional Director29 Apr 20192017₹28 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medione Pharmaceuticals Private Limited
Dewrock Infraprojects Private Limited
Premium access

Shareholding and investment profile for Aditya Jaiswal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aditya Jaiswal

Aditya Jaiswal was first appointed on 29 Apr 2019 as Additional Director at Dewrock Infraprojects Private Limited.

Aditya Jaiswal held 2 earlier board appointments: Medione Pharmaceuticals Private Limited (Director, 02 May 2019 to 30 Mar 2023); Dewrock Infraprojects Private Limited (Additional Director, 29 Apr 2019 to 31 Aug 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available